Synthetic Mesh Materials used for Pelvic Organ Prolapse Repair




This article will summarize findings by a review article published in the June, 2012 issue of Current Urology Reports Journal which assesses outcomes and complications when synthetic mesh is used in the surgical treatment of pelvic organ prolapse as well as FDA findings on the subject. Pelvic organ prolapse occurs when the muscles and tissues which hold such organs as the bladder, uretha, uterus and vagina in place break down, allowing the organs to move downward. The location of the defect determines its classification, including anterior (cystocele), posterior (rectocele) and apical (enterocele).

Traditional pelvic organ prolapse repair known as a colporrhaphy, either folds the native tissue or anchors them to surrounding structures. 17% of the repairs which use these techniques will require further surgical procedures. Grafts are used to strengthen weak tissues, decreasing the likelihood of recurrence. Graft use also allows surgeons to repair multiple sites in the same operation. Biologic grafts can consist of autografts (tissue from the same individual) allografts (tissue from another human) or xenografts (non-human organism tissue). Limitations to biologic grafts include cost, limited availability and the risk of disease transmission. Because of these limitations, synthetic mesh used in the repair of POP was approved by the FDA in 2001.

Synthetic grafts are classified according to filament number and pore size with variations in weight and flexibility. Type 1 mesh is macroporous, monofilament polypropylene, marketed under such brand names as Marlex, Atrium, Prolene, Gynemesh and Pelvitex. Type 1 mesh appears to have the highest rate of success due to its larger pore size which leads to better tissue grown and lower rates of infection. Despite this success rate, these vaginal mesh kits can provoke the body’s defense cell responses, causing the formation of granulomas.

The specific surgical technique used also has bearing on the rate of success in POP repair. Whether anterior, posterior or apical, the traditional colporrhaphy procedure may be implemented or the augmented procedure can be used. Regarding anterior repairs, mesh augmentation decreased recurrence rates however showed higher rates of complications. Apical compartment repairs also showed better results when mesh augmentation was used however no significant differences were noted between colporrhaphy and mesh augmented procedures when repairing the posterior compartment.

Complications associated with synthetic mesh kits are classified by the affected area, subdivided by time of occurrence such as an immediate physician-caused injury, short-term erosion and bleeding or long-term mesh extrusion, pain or painful sexual intercourse. According to the data in this particular article, incidence of erosion and extrusion range from 5-19%. Stress incontinence as a side effect of surgery occurred less often in colporrhaphy procedures than those which used surgical mesh. Painful sexual intercourse occurred equally in both groups, with the exception of a higher rate in posterior compartment colporrhaphy repairs. One study presented in the article noted that polypropylene meshes can retract up to 66% following surgery, leading to vaginal shortening and narrowing.

The French Health Authorities stated in 2006 that more research is required regarding the use of synthetic mesh in POP repair. The FDA followed in 2008 by issuing a public health notification regarding the use of synthetic mesh in POP repair. Suggestions offered included specialized physician training as well as using mesh only after weighing other alternatives. Physicians were advised to inform patients of potential complications as well as to ensure they understand that the mesh is considered permanent. An update to the 2008 notification was issued by the FDA in 2011 which stated that complications from the use of mesh in POP repair were “not rare” and that it was unclear whether the use of mesh showed any benefit over traditional repairs. Literature in this article, however, concluded that the FDA’s view was biased and that further research was necessary to compare colporrhaphy to repair using synthetic mesh kits.

No comments:

Post a Comment